Form 4: Agilon Health Director Karen McLoughlin Acquires 78,724 Restricted Stock Units

Agilon Health, Inc. Director Karen McLoughlin reported the acquisition of 78,724 restricted stock units, increasing her beneficial ownership to 151,890 shares.

Summary

• Karen McLoughlin, a Director of agilon health, inc. (AGL), acquired 78,724 shares of common stock on May 28, 2025.
• These shares were acquired at a price of $0, indicating they are a grant of restricted stock units (RSUs).
• The RSUs are scheduled to vest in full on May 28, 2026, contingent upon Ms. McLoughlin's continued service as a director.
• Following this transaction, Ms. McLoughlin beneficially owns a total of 151,890 shares of agilon health, inc. common stock, which includes these restricted stock units.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if through a grant, generally indicates continued commitment and alignment with the company's future, which is a positive signal. There are no negative financial implications or red flags in this specific filing.

Positives

• Director Karen McLoughlin increased her beneficial ownership in agilon health, Inc. by acquiring 78,724 restricted stock units, aligning her interests with long-term shareholder value.
• The grant of restricted stock units is a common form of equity compensation that incentivizes continued service and performance from directors.

Risks

• The vesting of the 78,724 restricted stock units is subject to Karen McLoughlin's continued service as a director until May 28, 2026; if her service ceases before this date, the units may be forfeited.

Future Outlook

The vesting of the newly acquired restricted stock units on May 28, 2026, indicates a future alignment of the director's compensation with the company's long-term performance and continued service.

Industry Context

This Form 4 filing reports an individual insider transaction, which is a routine disclosure for publicly traded companies. It does not provide broader industry context or trends, but rather reflects a standard equity compensation grant to a director within the healthcare services industry.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director can be viewed positively as it aligns management interests with shareholder value.

Next Steps

• Continued service of Karen McLoughlin as a director until May 28, 2026, for the restricted stock units to vest.

Key Dates

Keywords

agilon health, AGL, Form 4, SEC filing, insider transaction, restricted stock units, RSU, director compensation, equity grant, beneficial ownership